Toxoplasmosis in kidney transplant recipients: a life-threatening but treatable disease.
Renoult
E
E
Service de Néphrologie, Centre Hospitalier et Régional de Nancy, France.
Georges
E
E
Biava
M F
MF
Hulin
C
C
Frimat
L
L
Hestin
D
D
Kessler
M
M
D000328:Adult; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001344:Autopsy; D002981:Clindamycin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D011183:Postoperative Complications; D011739:Pyrimethamine / Q000627:therapeutic use; D012698:Serologic Tests; D013411:Sulfadiazine / Q000627:therapeutic use; D014123:Toxoplasmosis / Q000175:diagnosis* / Q000188:drug therapy* / Q000401:mortality
D000890:Anti-Infective Agents; D013411:Sulfadiazine; D002981:Clindamycin; D011739:Pyrimethamine